Not that any individual of any quality wouldn't want Ocata to be successful, but for an investor, an individual with any smarts able to analyze an investment, not to see that Ocata's in serious trouble, is just amazing to me.
Even if they somehow secure funding, based on what we know and can resonably assume going forward, it's pretty clear to me that we're looking at a share price much lower than today, as the company must continue to dilute to begin and fund any on-going clinicals (and avoid bk).
Without that, investors have next to nothing.
Ocata may somehow survive (whoever thought Geron and it's stem cell research would die?), but it's pretty clear to me that their dream will be at shareholders continuing dramatic losses in the days to come. Sad, but true. That's not bashing, but just assessing the hard realities that face the company and it's shareholders.
News 
Market Data 
Discover 
